XHKG
1179
Market cap12bUSD
Oct 07, Last price
33.10HKD
1D
0.98%
1Q
3.12%
IPO
6.43%
Name
H World Group Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
H World Group Limited, a prominent hospitality enterprise, focuses on the development and operation of hotels across the People's Republic of China. The company employs diverse business models, including leased and owned properties, manachised establishments, and franchised locations. Its extensive brand portfolio features numerous well-known names such as HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, Ibis Hotel, JI Hotel, Orange Hotel, Starway Hotel, Ibis Styles Hotel, CitiGO Hotel, Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, MAXX by Steigenberger, Jaz in the City, Grand Mercure, Steigenberger Icon, and Song Hotels. By June 30, 2022, H World Group oversaw a substantial network comprising 8,176 hotels and 773,898 rooms. Founded in 2005 and headquartered in Shanghai, the company underwent a name change from Huazhu Group Limited to H World Group Limited in June 2022.
Related entities
Subsidiaries (3)
CHINA LODGING HOLDINGS (HK) LIMITED
Huazhu Investment I Limited
Huazhu Investment II Limited
Key people
Hui Jin
Co-President · since 2019
Executive Vice-Chairlady · since 2019
Jiong Wu
Co-Founder, Independent Director · since 2007
Tong Tong Zhao
Co-Founder, Independent Director · since 2007
Teo Nee Chuan
Chief Financial Officer · since 2016
Director · since 2016
Director · since 2018
Yan Huang
Independent Director · since 2007
Legal address
PO Box 2681 Cricket Square Hutchins Drive
George Town KY1-1111
KY
George Town KY1-1111
KY
Headquarters
嘉定区
嘉定区, SH 201803
CN
嘉定区, SH 201803
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||